So Coleys CPG 'toll like receptor9' agonist ProMune has just been licensed out to Pfizer in a deal worth more than 1/2 billion dollars in payments plus royalties on top of that . ProMune , combined with 2 front line chemos , demonstrated they are almost as good as RTs BEC (Coramsine) NSCLC response results as a stand alone treatment . At what point I wonder does Solbec become worth more than 20m ?
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.